Sio Gene Therapies Inc. Profile Avatar - Palmy Investing

Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize …

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Sio Gene Therapies Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Sio Gene Therapies Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Sio Gene Therapies Inc..

End of SIOX's Analysis
CIK: 1636050 CUSIP: 829399104 ISIN: US8293991043 LEI: - UEI: -
Secondary Listings
SIOX has no secondary listings inside our databases.